Cargando…
Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barré syndrome
Soluble receptor for advanced glycation end products (sRAGE) is an anti-inflammatory factor that mitigates the proinflammatory effects of high mobility group box 1 (HMGB1). The aim of this study was to investigate whether Guillain-Barré syndrome (GBS)-related inflammation are mediated by sRAGE and H...
Autores principales: | Zhang, Da-Qi, Wang, Rong, Li, Ting, Zhou, Jian-Ping, Chang, Guo-Qiang, Zhao, Ning, Yang, Li-Na, Zhai, Hui, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763208/ https://www.ncbi.nlm.nih.gov/pubmed/26902096 http://dx.doi.org/10.1038/srep21890 |
Ejemplares similares
-
Prediction of Functional Outcome in Axonal Guillain-Barre Syndrome
por: Sung, Eun Jung, et al.
Publicado: (2016) -
Respiratory paralysis in a child: The severe axonal variant of childhood Guillain-Barré syndrome
por: Ravishankar, N.
Publicado: (2015) -
Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome
por: Wen, Puyuan, et al.
Publicado: (2021) -
Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome
por: Yadegari, Samira, et al.
Publicado: (2014) -
Nodopathies in the Early Diagnosis of Axonal Forms of Guillain-Barré Syndrome
por: Urdiales-Sánchez, Sara, et al.
Publicado: (2022)